The Readout Loud
Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Can pharma-shaming get someone re-elected? How rare is too rare when it comes to biotech research? And what does "positive" even mean, really?